AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16258098
Drug: Antibiotics plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics plus G-CSF
Trial: 12011969
Drug: HR 500
RxNorm normalized name: Glucophage XR 24 HR 500 MG Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HR 500 mg tid (Group A)
Trial: 12011969
Drug: HR 1
RxNorm normalized name: Wal-Fex 24 HR 180 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HR 1 g tid (Group B)
Trial: 12011969
Drug: HR 1
RxNorm normalized name: Wal-Fex 24 HR 180 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HR 1 g/day (Group D)
Trial: 27084825
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate (220 mg, 110 mg twice daily for 4 days)
Trial: 24670356
Drug: CC/CT+TT (wild
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC/CT+TT (wild type GSTP1 exon 6)
Trial: 21626817
Drug: Phenotropil, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenotropil, 400 mg/day for 1 year
Trial: 16140624
Drug: Test substances
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test substances (glue, body wash solution, dryer sheet)
Trial: 16140624
Drug: Body wash
RxNorm normalized name: Olay Body Wash
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Body wash solution
Trial: 8712125
Drug: Aminophylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (400 mg, oral administration for 90 minutes)
Trial: 8712125
Drug: Nitroglycerin (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (0.3 mg, sublingual)
Trial: 31730554
Drug: Initial prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial prescription of 30 hydrocodone/acetaminophen pills (5/325 mg)
Trial: 31730554
Drug: Initial prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial prescription of 10 hydrocodone/acetaminophen pills (5/325 mg)
Trial: 27101805
Drug: Tadalafil 20‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20‐mg (on‐demand)
Trial: 27101805
Drug: Sildenafil 100‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 100‐mg (on‐demand)
Trial: 26226090
Drug: Cognitive Behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavior Therapy (CBT) with routine primary care; 12 weekly 50-min sessions
Trial: 8432466
Drug: Erythromycin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (200 mg)
Trial: 15083940
Drug: Neostigmine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (2 mg)
Trial: 11475343
Drug: 7.5% icodextrin-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5% icodextrin-containing solution
Trial: 9727896
Drug: Hypocaloric diet
RxNorm normalized name: Hydrochloric Acid
DrugBank: Hydrochloric acid (DB13366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypocaloric diet plus metformin
Trial: 2153334
Drug: Acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetate infusion (2.5 mmol/min)
Trial: 2153334
Drug: Acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetate infusion (2.5 mmol/min) with glucose (20 g/m2 body surface area)
Trial: 2153334
Drug: Bicarbonate infusion
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate infusion (2.8 mmol/min)
Trial: 273932
Drug: Mouthwash formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mouthwash formulations (specific formulations not detailed)
Trial: 31366875
Drug: β-CRX-rich orange
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-CRX-rich orange juice (125 mL, after breakfast)
Trial: 31366875
Drug: Placebo (β-CRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (β-CRX removed from orange juice, 125 mL, after breakfast)
Trial: 25765784
Drug: Four mini-implants
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four mini-implants (GI)
Trial: 25765784
Drug: Two mini-implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two mini-implants (GII)
Trial: 25765784
Drug: Two standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two standard implants (GIII)
Trial: 19388860
Drug: Olfactory stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olfactory stimulation with cherry-flavored scent in oxygen (4 L/min)
Trial: 30847444
Drug: Oral piracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral piracetam
Trial: 9721974
Drug: Conventional intensive
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional intensive care treatment
Trial: 8306739
Drug: Artificial lung‐expanding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial lung‐expanding compound (ALEC, 3.2 g via bronchoscope)
Trial: 23290818
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for persistent dementia cases
Trial: 23290818
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for persistent non-cognitive psychiatric disorder cases
Trial: 8262872
Drug: Imipenem/cilastatin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin (500 + 500 mg qds)
Trial: 8262872
Drug: Aztreonam (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aztreonam (600 tds) and Clindamycin (1000 mg tds)
Trial: 4037642
Drug: Caudal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine 10 mg in saline 25 ml injected into the caudal epidural space at the end of surgery
Trial: 4037642
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine 10 mg on request in the postoperative period
Trial: 4037642
Drug: Caudal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine 10 mg
Trial: 30673030
Drug: Needleless jet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needleless jet injection system
Trial: 27276234
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (systolic blood pressure target of 110 to 139 mm Hg)
Trial: 27276234
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (systolic blood pressure target of 140 to 179 mm Hg)
Trial: 22753922
Drug: Motesanib 125
RxNorm normalized name: Motesanib
DrugBank: Motesanib (DB05575)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motesanib 125 mg plus carboplatin/paclitaxel
Trial: 20003585
Drug: Topical 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5-fluorouracil 5 percent cream, three successive applications with two-week intervals
Trial: 20003585
Drug: Local petroleum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local petroleum jelly cream packing
Trial: 20003585
Drug: Topical 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5-fluorouracil 5 percent cream
Trial: 17068214
Drug: Caffeine capsules
RxNorm normalized name: Butalbital, Aspirin, and Caffeine Capsules
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine capsules (dose = 4 mg/kg)
Trial: 9595967
Drug: Metrifonate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate (100 to 180 mg loading dose for 2 weeks, followed by 30 to 60 mg maintenance dose for 24 weeks)
Trial: 8572867
Drug: Antihypertensive drug
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drug treatment for 3 months
Trial: 2705806
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron (n = 17)
Trial: 25534375
Drug: Anthracycline-plus-taxane combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-plus-taxane combination with carboplatin (PMCb)
Trial: 25534375
Drug: Anthracycline-plus-taxane combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-plus-taxane combination (PM)
Trial: 21878677
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d)
Trial: 27370892
Drug: Betamethasone 8
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone 8 mg
Trial: 12059822
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 2 ml (placebo)
Trial: 11072160
Drug: Amifostine during
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amifostine during radiation therapy (RT)
Trial: 3324039
Drug: Intralesional steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional steroid injection (2.5 mg) and griseofulvin
Trial: 15316334
Drug: peg-IFN alpha-2a
RxNorm normalized name: PEG-IFN alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: peg-IFN alpha-2a 180 microg once weekly plus ribavirin 400 mg twice daily
Trial: 15316334
Drug: IFN alpha-2a
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN alpha-2a 3 million units three times weekly plus ribavirin 400 mg twice daily
Trial: 18664620
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral doses of pantoprazole (20 mg or 40 mg)
Trial: 18664620
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous doses of pantoprazole (0.8 mg/kg or 1.6 mg/kg)
Trial: 18664620
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of pantoprazole (oral and intravenous)
Trial: 16650135
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) 300 mg daily
Trial: 9001830
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg suspension
Trial: 9001830
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg capsule (laboratory batch)
Trial: 9001830
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg capsule (production batch)
Trial: 31613883
Drug: Community treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community treatment using ready-to-use therapeutic food
Trial: 20663779
Drug: Oral screen
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral screen (OS) application
Trial: 17978594
Drug: Nebivolol (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (2.5, 5, 10, 20, or 40 mg once daily)
Trial: 17978594
Drug: Nebivolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (10 mg and higher)
Trial: 14534925
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of regular-release (RR) and sustained-release (SR) levodopa/benserazide
Trial: 11069460
Drug: Finasteride 1
RxNorm normalized name: finasteride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 1 mg daily for 48 weeks
Trial: 1970584
Drug: SK&F 104353
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK&F 104353 (800 micrograms inhaled)
Trial: 6379136
Drug: Immediate administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate administration of a three-dose course of intravenously administered indomethacin in addition to usual medical therapy (fluid restriction and use of diuretics or digitalis or both)
Trial: 6379136
Drug: Usual medical
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual medical therapy alone initially, with indomethacin as the first and surgery as the final backup measure
Trial: 6379136
Drug: Usual medical
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual medical therapy alone initially, with surgery alone as backup
Trial: 6379136
Drug: Usual medical
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual medical therapy with surgery as backup
Trial: 6379136
Drug: Indomethacin as
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin as part of initial treatment
Trial: 23374677
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 0.5 mg
Trial: 23374677
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 2 mg
Trial: 17244900
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine infused intra‐articular at 4 mL/hour for 72 hours
Trial: 17244900
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline infused intra‐articular at 4 mL/hour for 72 hours (placebo)
Trial: 17244900
Drug: No intra‐articular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intra‐articular infusion catheter (control)
Trial: 8797186
Drug: Nortriptyline (NT)
DrugBank: Nortriptyline (DB00540)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nortriptyline (NT) 75 mg daily for up to 7 weeks
Trial: 8041232
Drug: Ethanol (0.85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.85 g/kg)
Trial: 8041232
Drug: Cocaine HCl
RxNorm normalized name: cocaine HCl
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine HCl (1.25 and 1.9 mg/kg)
Trial: 1640806
Drug: Ethanol (0.85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.85 g/kg) with Cocaine
Trial: 6151505
Drug: Propranolol (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (maximum 170 mg)
Trial: 6151505
Drug: Metoprolol (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (maximum 187.5 mg)
Trial: 6151505
Drug: Propranolol (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (various doses: 10 mg, 17.5 mg, 45 mg)
Trial: 6151505
Drug: Metoprolol (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (various doses: 37.5 mg, 187.5 mg)
Trial: 6151505
Drug: Inhaled isoprenaline
RxNorm normalized name: isoprenaline
DrugBank: Isoprenaline (DB01064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled isoprenaline
Trial: 26847307
Drug: CC depth
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC depth of 6-7 cm (G 6-7)
Trial: 26847307
Drug: CC depth
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC depth of 5-6 cm (G 5-6)
Trial: 20084363
Drug: Routine follow-up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine follow-up and monthly telephone contact
Trial: 15911037
Drug: Psychopharmacological therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychopharmacological therapy
Trial: 12790358
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of Tc-99m-HMPAO
Trial: 12790358
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of Tc-99m-HMPAO
Trial: 12790358
Drug: Tc-99m-HMPAO adherence
RxNorm normalized name: Technetium tc 99m HMPAO
DrugBank: Technetium Tc-99m exametazime (DB09163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tc-99m-HMPAO adherence to mucus after inhalation
Trial: 10559508
Drug: HMG CoA
RxNorm normalized name: HMG CoA reductase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG CoA reductase inhibitor medication (statins)
Trial: 1781468
Drug: Overall prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall prescription error rate
Trial: 28294380
Drug: Intra-oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-oral placebo appliance
Trial: 21102589
Drug: Figitumumab (F)
RxNorm normalized name: Stomodine F
DrugBank: Figitumumab (DB11685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Figitumumab (F) at doses of 10 or 20 mg/kg (PCF10, PCF20)
Trial: 20212496
Drug: Taranabant 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taranabant 0.5 mg
Trial: 20212496
Drug: Taranabant 1
RxNorm normalized name: Taranabant
DrugBank: Taranabant (DB06624)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taranabant 1 mg
Trial: 20212496
Drug: Taranabant 2
RxNorm normalized name: Taranabant
DrugBank: Taranabant (DB06624)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taranabant 2 mg
Trial: 12599994
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 60 g/day soy protein
Trial: 12599994
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 30 g/day soy protein
Trial: 12599994
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 45 g/day soy protein
Trial: 8563662
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CB)
Trial: 10224730
Drug: Psychodynamic-interpersonal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychodynamic-interpersonal therapy (PI)
Trial: 8563662
Drug: Sixteen sessions
RxNorm normalized name: Alternanthera sessilis extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sixteen sessions of therapy
Trial: 30926189
Drug: Intranasal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ketamine (0.75 mg/kg)
Trial: 30926189
Drug: Intranasal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal placebo (saline solution)
Trial: 21252259
Drug: Endotoxin core
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Endotoxin core antibody (EndoCAb)
Trial: 19503012
Drug: Prednisolone 60
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone 60 mg daily for 5 days, then tapering for 5 days plus placebo
Trial: 19503012
Drug: Valacyclovir 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1,000 mg 3 times daily for 7 days plus placebo
Trial: 12544447
Drug: Low salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low salt (7.8 +/- 0.9 to 11.2 +/- 1.4 ml/min per 100 ml)
Trial: 12544447
Drug: High salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High salt (8.5 +/- 1.2 to 10.4 +/- 1.3 ml/min per 100 ml)
Trial: 10871469
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone agonist therapy
Trial: 9062479
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose T3 treatment for 63 days
Trial: 9439537
Drug: T3 treatment
RxNorm normalized name: T3
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T3 treatment
Trial: 3534021
Drug: Topical tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tretinoin (retinoic acid and Retin-A) delivered by cervical cap and inert collagen sponge system
Trial: 25244700
Drug: Drug-eluting balloons
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting balloons (DEB)
Trial: 20585000
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day modafinil
Trial: 10100363
Drug: DDAVP spray
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: DDAVP spray at 20 mcg/day for 6 weeks
Trial: 10100363
Drug: DDAVP spray
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: DDAVP spray at 30 mcg/day for 6 weeks
Trial: 10100363
Drug: DDAVP spray
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: DDAVP spray at 20 mcg/day for 2 weeks, then 30 mcg/day for 2 weeks after washout
Trial: 10100363
Drug: DDAVP spray
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: DDAVP spray at 30 mcg/day for 2 weeks, then 20 mcg/day for 2 weeks after washout